Israeli biotech BiomX is developing a pipeline of treatments for unmet medical needs, including cancer, inflammatory bowel disease and acne.  BiomX focuses on modulating the human microbiome – bacteria that reside in and on the human body – to boost … Continue reading →

Back in June 2011 I reported on BreathID from Israel’s Exalenz, which tests for H. pylori. The bacterium causes peptic ulcers and gastric inflammation, and is associated with stomach cancer. Today, BreathID is used in 220 US centers, producing results … Continue reading →

A team of microbiologists, including Professor Eshel Ben-Jacob of Tel Aviv University, has discovered that cancer cells and bacteria behave in the same way as terrorists do in real life. They spy out the body, manipulate genes, enslave normal cells … Continue reading →

Israel’s NeoTX (see here previously) is now conducting a Phase 2 trial of its naptumomab estafenatox (NAP) bacteria-coated, immunotherapy cancer treatment on 30 patients in the US. It is also enhancing an AstraZeneca checkpoint inhibitor. NeoTX has 3 Nobel prizewinners … Continue reading →

As reported previously (see here) Israel’s Biomica is using the human microbiome (stomach bacteria) to fight cancer, IBD, acne etc. Bionica is starting pre-clinical studies for BMC321 & BMC322, two developed microbial consortia aimed to treat Inflammatory Bowel Disease (IBD). … Continue reading →